This study aims to estimate prostate cancer cell survival following Ac-225-PSMA targeted radionuclide therapy by integrating physiologically based pharmacokinetic (PBPK) modeling, Monte Carlo simulations, and the two-lesion kinetic (TLK) radiobiological model...
Milad Peer-firozjaei, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine